Building a Serialisation Blueprint: How Early-Stage Planning Can Drive Commercial Success in Pharma

Pharmaceutical manufacturers come together to share experiences, insights, and strategies.

26

September

  • 10am CDT | 4pm BST
  • Free
  • Why attend?
  • Speakers
  • Contact Us

Why attend?

Speakers

Select a speaker to learn more

Back
Jeff Primeau
Vice President, Business Solutions, AmeriscourceBergen ICS

Jeff Primeau is Vice President of Business Solutions for ICS. He is an accomplished supply chain executive with more than 25 years of experience in the industry. As a member of the executive lead team for ICS, he leads the long-term strategy and manages execution and delivery of key initiatives to efficiently scale while continuing to provide unsurpassed service levels to our clients. For the past five years, he has led the design, development, and execution of a cross functional strategy to deploy a new distribution model to support the Drug Supply Chain Security Act (DSCSA).

Next speaker
Back
Tracie Sasaki
Director of Operations, AmerisourceBergen ICS Reno Distribution Center

Tracie Sasaki is the Director of Operations at the AmerisourceBergen /ICS Reno Distribution Center. She has been with AB for three years, following a career at FedEx Express that spanned twenty-nine years. Tracie is certified in Lean Competency, Six Sigma, and Quality Driven Management.

Tracie was a Division I student athlete swimmer at the University of Nevada-Reno earning a degree in Physical Education with a minor in History.

Next speaker
Back
Ryan Majewski
Associate Director, US Commercial Supply Chain, Krystal Biotech, Inc.
Next speaker
Back
Madison Leigh
Manager, Integrated Solutions, ICS Corporate Design & Development

Madison Leigh is the Secure Supply Chain Manager for ICS. She leads serialization onboarding efforts, with both manufacturers and their downstream customers, to support the Drug Supply Chain Security Act (DSCSA). While managing hundreds of onboardings and integrations throughout the years, she has become an expert in the matter and guides the organizations with valuable lessons learned and helps them avoid the many challenges they could encounter.

Next speaker
Back
Kristy Dinh
Director, Applications Delivery, ICS Technology & Innovative Solutions

Kristy Dinh is Director of IT- Applications Delivery for ICS. She has over 20 years of experience in Healthcare, Government, and 3PL Logistics. Kristy successfully deployed and supported several IT Application Delivery projects, including ERP Migrations, BI Reporting, and TMS. For the past seven years, Kristy has been leading the IT efforts to successfully support the Drug Supply Chain Security Act requirements for ICS's 3PL and Title models.

Next speaker
Back
Jeff Bragar
Senior Manager, Commercial Supply Chain, Ferring Pharmaceuticals, Inc.

Jeff has been both an educator and practitioner of Supply Chain Management. He has held positions of increasing responsibility in Production Planning, Inventory Control and ERP implementations for over 20 years as well as teaching Operations and Supply Chain Management classes at the college level. He currently manages supply chain and serialization for Ferring Pharmaceuticals, Inc. His educational credentials include a BS in Management from Montclair State University, an MBA from Fairleigh Dickinson University and both CPIM and CIRM designations from APICS.

Next speaker
Back
Andrew Thompson
Director of Therapy Research & Analysis, Medical Devices, GlobalData

Andrew Thompson is the Director of Therapy and Analysis at GlobalData Healthcare, responsible for data collection and forecasting within the Medical Devices portfolio. Andrew is passionate about developing innovative approaches to the world of medical devices industry research. Andrew joined the team in 2012, following 20 years working within the academic and industry sectors, developing a specialty in advanced diagnostics for infectious disease. With multiple patents in molecular detection technologies, publications’ covering a breadth of topics and leading product development teams, Andrew has established a strong reputation within molecular diagnostics. Having worked on the frontline, Andrew can share a global understanding of the medical device industry, with both a highly developed understanding of the technologies, new and emerging, and of the business dynamics fueling medical device usage in healthcare.

Responsible for the content and direction of global medical device portfolios, GlobalData forward-looking approach generates stimulating analysis and reports, to explore what these changes mean for GlobalData’s clients and their customers.

Next speaker

Enquiry